AI-generated summary
The authors reviewed recent randomized controlled trials of photobiomodulation therapy for oral mucositis caused by head and neck radio-chemotherapy in adult and pediatric cancer patients. They report that the therapy was associated with reduced severity and duration of mucositis and improved patient-reported outcomes. They note that results across studies are controversial and that treatment protocols are not standardized, and that long-term follow-up studies are needed.
- Who or what was studied
- Adult and pediatric cancer patients receiving head and neck radio-chemotherapy who develop oral mucositis
- Wavelengths
- 630, 980 nm
- Limits stated in the abstract
- The abstract notes controversy among study results, variability and limited standardization of protocols, and the need for long-term follow-up studies.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 630-980 nm
- Energy density (fluence)
- 6 J/cm2
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, Inflammation, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.